PROADRENOMEDULLIN AS MARKER INDICATING UNFAVORABLE EVENT Russian patent published in 2022 - IPC G01N33/68 G01N33/53 

Abstract RU 2775090 C2

FIELD: medical diagnostics.

SUBSTANCE: method for the prediction of a lethal outcome in a subject suffering from sepsis is disclosed, including the determination of a proadrenomedullin (hereinafter – proADM) level in a sample of this subject, where the proADM level lower than 0.88 nmol/l indicates the survival of the subject during approximately 28 days, while the subject has an assessment on a dynamic organ failure assessment scale (SOFA scale) ≤ 6.

EFFECT: invention provides for a fast and reliable method for the prediction of a lethal outcome in a subject.

15 cl, 4 dwg, 9 tbl, 2 ex

Similar patents RU2775090C2

Title Year Author Number
HISTONES AND/OR proADM AS MARKERS INDICATING ADVERSE EVENT 2017
  • Tsira Tim
  • Shenikhen Andre
  • Enkam Ann
  • Krop Manne
  • Kurdt Ingo
  • Sharl Per-Emmanyuel
RU2765212C2
HISTONES AND/OR proADM AS MARKERS TESTIFYING ABOUT ORGAN DYSFUNCTION 2017
  • Tsira Tim
  • Drejer Frauke
  • Enkam Ann
  • Krop Manne
  • Sharl Per-Emmanyuel
RU2764766C2
PROADM FOR PREDICTING RISK OF CONDITION REQUIRING HOSPITALIZATION IN PATIENTS WITH SYMPTOMS OF INFECTIOUS DISEASE 2019
  • Vilson, Darius
  • Bermekho Martin, Khesus Fransisko
  • Garsiya Ortis, Luis
  • Errero Rodriges, Karmen
RU2820944C2
PRESCRIBING REMOTE PATIENT MANAGEMENT BASED ON BIOMARKERS 2020
  • Stubbe, Tobias
  • Wiemer, Jan
  • Kunde, Jan
  • Gehrig, Stefan
  • Kohler, Friedrich
RU2822013C2
PRO-ADM AS MONITORING MARKER OF THERAPY FOR CRITICALLY ILL PATIENTS 2018
  • Wilson Darius
RU2782305C2
PROCALCITONIN AND PRO-ADM AS MARKERS FOR MONITORING OF TREATMENT WITH ANTIBIOTICS 2018
  • Wilson Darius
RU2788885C2
MR-proADM AS MARKER FOR EXTRACELLULAR VOLUME STATUS OF SUBJECT 2016
  • Vigue, Bernard
  • Rafi-Nikoukhah, Homa
RU2778457C2
TREATMENT, DIAGNOSTICS OR PREVENTION OF LEISHMANIASIS CAUSED BY VARIOUS TYPES OF PARASITES, EXCEPT THAT ONE USED TO PRODUCE HISTONES, WITH USING ALL OF FOUR HISTONES H2A, H2B, H3 AND H4, RECOVERED FROM LEISHMANIA INFANTUM WITH USING VECTOR CONTAINING NUCLEOTIDES CODING SPECIFIED HISTONES 2004
  • Al'Vares Manuehl' Soto
  • Iborra Sal'Vador
  • Rekena Khose Marija
  • Bedate Karlos Alonso
RU2380710C2
MONOCLONAL ANTIBODY, WHICH HAS IMMUNOSUPRESSIVE ACTIVITY, OR ITS ANTIGEN-BINDING FRAGMENT 2011
  • Sato Sudzi
  • Goto Takeshi
  • Goto Sigeru
  • Nakano Tosiaki
  • Okhmori Naoja
  • Tiang Kueiten
  • Simada Jaei
  • Mori Kendzi
  • Mijagi Takamitsu
RU2559550C2
METHOD OF OUTCOME FORECAST OF DISEASE OF PATIENTS WITH URGENT SURGICAL PATHOLOGY OF ORGANS OF ABDOMINAL CAVITY 2007
  • Sarap Pavel Vladimirovich
  • Vinnik Jurij Semenovich
RU2352948C1

RU 2 775 090 C2

Authors

Wilson, Darius Cameron

Bermejo, Jesus

Andaluz, David

Calvo, Dolores

Dates

2022-06-28Published

2018-02-01Filed